Observational studyAlzheimer disease and associated disorders
Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease.
Yu Nakamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.